Cannabinoid receptor

• Understanding the role of the CB1 toggle switch in interaction networks using molecular dynamics simulation (05 Sep 2022)
  
• The Impact of CB1 Receptor on Nuclear Receptors in Skeletal Muscle Cells (05 Sep 2022)
  
• The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies (05 Sep 2022)
  
• Quality of Life and a Surveillant Endocannabinoid System (05 Sep 2022)
  
• New Pyridone-Based Derivatives as Cannabinoid Receptor Type 2 Agonists (05 Sep 2022)
  
• Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors? (05 Sep 2022)
  
• Kahweol, a natural diterpene from coffee, induces peripheral antinociception by endocannabinoid system activation (05 Sep 2022)
  
• Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses (01 Sep 2022)
  
• Editorial: Challenges and Conundrums in Cannabinoid-Based Treatments for Epilepsy Syndromes and Associated Neurobehavioral Comorbidities (01 Sep 2022)
  
• The systems medicine of cannabinoids in pediatrics: the case for more pediatric studies (27 Aug 2022)
  
• Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression (27 Aug 2022)
  
• Cannabinoids in Medicine: Cancer, Immunity, and Microbial Diseases (27 Aug 2022)
  
• Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment (27 Aug 2022)
  
• Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition (13 Aug 2022)
  
• In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties (13 Aug 2022)
  
• Considerations for Cannabinoids in Perioperative Care by Anesthesiologists (13 Aug 2022)
  
• Components of the Endocannabinoid System and Effects of Cannabinoids Against Bone Diseases: A Mini-Review (13 Aug 2022)
  
• Cannabinoids in Chronic Pain: Therapeutic Potential Through Microglia Modulation (13 Aug 2022)
  
• New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders (07 Aug 2022)
  
• Identification of Novel Cannabinoid CB2 Receptor Agonists from Botanical Compounds and Preliminary Evaluation of Their Anti-Osteoporotic Effects (07 Aug 2022)
  
• The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation (05 Aug 2022)
  
• Targeting the Endocannabinoidome in Pancreatic Cancer (05 Aug 2022)
  
• Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination (05 Aug 2022)
  
• Chronic Pain and the Endocannabinoid System: Smart Lipids – A Novel Therapeutic Option? (05 Aug 2022)
  
• Cannabinoids, their cellular receptors, and effects on the invasive phenotype of carcinoma and metastasis (05 Aug 2022)
  
• Botanically-Derived Δ9-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from People with Multiple Sclerosis (05 Aug 2022)
  
• A Low Dose of Pure Cannabidiol Is Sufficient to Stimulate the Cytotoxic Function of CIK Cells without Exerting the Downstream Mediators in Pancreatic Cancer Cells (05 Aug 2022)
  
• The Endocannabinoid System: A Potential Therapeutic Target for Coagulopathies (31 Jul 2022)
  
• The Autism–Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System (31 Jul 2022)
  
• South African Family Practice (31 Jul 2022)
  
• Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders (31 Jul 2022)
  
• Medicinal Cannabis and Central Nervous System Disorders (31 Jul 2022)
  
• Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action (31 Jul 2022)
  
• Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review (31 Jul 2022)
  
• Impact of Cannabinoid Compounds on Skin Cancer (31 Jul 2022)
  
• Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty (31 Jul 2022)
  
• A critical review of cannabis in medicine and dentistry: A look back and the path forward (31 Jul 2022)
  
• Involvement of the endocannabinoid system in the inhibition of Sindbis virus replication: a preliminary study - Journal of Cannabis Research (26 Jul 2022)
  
• CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature - Journal of Cannabis Research (26 Jul 2022)
  
• Endocannabinoid System and Migraine Pain: An Update (25 Jul 2022)
  
• Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease – A Systematic Review (21 Jul 2022)
  
• Endocannabinoid Discovery Timeline (21 Jul 2022)
  
• Encouraging Cancer Research (21 Jul 2022)
  
• Coffee & Cannabis (21 Jul 2022)
  
• CBD & the Psychedelic Receptor (21 Jul 2022)
  
• Cannabis and Cannabinoids (PDQ®)–Health Professional Version (21 Jul 2022)
  
• Cannabinoids: The Science Behind Medical Cannabis (20 Jul 2022)
  
• Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease (20 Jul 2022)